Finally, the effect of NF-κB inhibition on genes involved in immunoregulation is also in accordance with previous AML studies [6], and with the initial discovery of NF-κB as an enhancer of B-cell functions [7]. The gene discussed is NFKB1; the disease is acute myeloid leukemia.